The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis
CompletedOBSERVATIONAL
Enrollment
5
Participants
Timeline
Start Date
October 13, 2021
Primary Completion Date
December 23, 2022
Study Completion Date
December 23, 2022
Conditions
Cystic Fibrosis
Trial Locations (1)
CB2 0AA
Royal Papworth Hospital, Cambridge
All Listed Sponsors
lead
Papworth Hospital NHS Foundation Trust
OTHER_GOV
NCT05944367 - The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis | Biotech Hunter | Biotech Hunter